Activity value 84india Buyer&Supplier,Last transaction date:
2023-06-05Address: 503 504 5th floor hubtown solaris n.s.phadke marg andheri- east. mumbai 400069. india., maharashtra, india
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for unosource pharma ltd. from 2022 to 2023.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2023, the company has completed 4 transactions, with a transaction quantity of 16860 and a transaction weight of 16860.
YearTransactionsQuantityWeight
2022000
202341686016860
Bill of lading data
<
1/15
>
Trade date
2023/06/05
B/L No.
c5ebdt5nzeb18
Suppliers
medizone healthcare co
Buyers
unosource pharma ltd.
5farmabios s.p.a.
argentinabuyer,they trade on 2018-07-07
10.7%
>
Products
Total 4
ProductsTransactionsPerDetail
medicine 4100%>
turn 4100%>
bat 4100%>
pharmaceutical product 4100%>
Hscode rank
Total 24
HSCode NameTransactionsPerDetail
HS 300490994100%>
Trading Area
Total 5
AreaTransactionsPerDetail
netherlands85.59%>
singapore42.8%>
india21.4%>
italy10.7%>
united states10.7%>
Port statistics
Total 3
Port NameTransactionsPerDetail
sahar air cargo acc inbom49969.23%>
delhi21.4%>
inbom410.7%>
unosource pharma ltd. is india Buyer&Supplier,
and primarily engages in the import and export business of products such as medicine,turn,bat.
According to the 52wmb.com global trade database, as of 2023-06-05, the company has completed 19312 international trades,
with its main trading regions covering netherlands,singapore,india etc.
The core products include HS30049099 etc,
often transported via sahar air cargo acc inbom4,port delhi, port inbom4 etc,
and its main trading partners are aspen oss b.v.,medizone healthcare co,samkom pharma trade.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on unosource pharma ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.